MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Weisberg E et al. | A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol. | 1999 | Contraception | pmid:10494484 |
Weisberg E et al. | Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring. | 1999 | Contraception | pmid:10494485 |
Mendoza-RodrÃguez CA et al. | Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites. | 1999 | Contraception | pmid:10494488 |
Muneyyirci-Delale O and Karacan M | Hormonal treatment of bilateral proximal tubal obstruction. | 1999 Jun-Aug | Int J Fertil Womens Med | pmid:10499742 |
Archer DF et al. | A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group. | 1999 | Obstet Gynecol | pmid:10511348 |
Bjarnason K et al. | Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. | 1999 | Maturitas | pmid:10515673 |
el Nahal N et al. | Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion. | 1999 | Contraception | pmid:10518231 |
Tran A et al. | Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. | 1999 | Am. J. Gastroenterol. | pmid:10520843 |
Lewis-Barned NJ et al. | Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. | 1999 | J. Clin. Endocrinol. Metab. | pmid:10522991 |
Collier TM et al. | Mesenteric thrombosis associated with oral contraceptives. | 1975 Jul-Aug | Angiology | pmid:1053592 |